- Previous Close
31.00 - Open
33.68 - Bid 32.66 x --
- Ask 32.72 x --
- Day's Range
32.50 - 34.26 - 52 Week Range
30.40 - 53.75 - Volume
229,875 - Avg. Volume
632,754 - Market Cap (intraday)
8.909B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
17.87 - EPS (TTM)
1.83 - Earnings Date Apr 29, 2025
- Forward Dividend & Yield 0.95 (2.76%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
41.40
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.
www.arjo.com/int/6,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ARJO-B.ST
View MorePerformance Overview: ARJO-B.ST
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ARJO-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ARJO-B.ST
View MoreValuation Measures
Market Cap
8.44B
Enterprise Value
12.97B
Trailing P/E
16.94
Forward P/E
12.55
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.75
Price/Book (mrq)
1.01
Enterprise Value/Revenue
1.15
Enterprise Value/EBITDA
6.44
Financial Highlights
Profitability and Income Statement
Profit Margin
4.41%
Return on Assets (ttm)
4.05%
Return on Equity (ttm)
6.26%
Revenue (ttm)
11.29B
Net Income Avi to Common (ttm)
498M
Diluted EPS (ttm)
1.83
Balance Sheet and Cash Flow
Total Cash (mrq)
1.04B
Total Debt/Equity (mrq)
65.41%
Levered Free Cash Flow (ttm)
578.63M